Exablate Model 400 Type 1.0 & Type 1.1 (Exablate Neuro)
FDA premarket approval P150038/S025 · decided 2023-10-12
Approval details
- PMA number
- P150038
- Supplement
- S025
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Exablate Model 400 Type 1.0 & Type 1.1 (Exablate Neuro)
- Generic name
- MR-guided focused ultrasound system
- Applicant
- Insightec
- Date received
- 2023-01-18
- Decision date
- 2023-10-12
- Days to decision
- 267 days
- Decision code
- APPR
- Product code
- POH
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Tirat Carmel
- Statement
- approval for a new software version 9.0 and hardware changes for the Exablate Model 4000 Type 1.1 System
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.